Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Peripheral blood cfDNA detection using clonoSEQ assay in multiple myeloma is concordant with bone marrow and clinical biomarkers.”
Title: Peripheral blood cfDNA detection using clonoSEQ assay in multiple myeloma is concordant with bone marrow and clinical biomarkers
Authors: J. E. Wiedmeier-Nutor, H. E. Kosiorek, M. Arribas, H. Simmons, A. Jacob, S. S. Bhattu, R. Fonseca, L. Bruins, G. Ahmann, U. Yadav, S. Chhabra, P. L. Bergsagel
You can read the Full Article in Blood Cancer Journal.
You can find other articles featuring Robert Orlowski on OncoDaily.
